GlassScriptPhysician profile
Cassidy N Conley
NPI 1053828657
$15,647.56
in general payments reported to CMS, 2019-2025
27 companies · $3,955 in 2025
The $3,955 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $998 · 2022: $3,312 · 2023: $2,882 · 2024: $4,501 · 2025: $3,955.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,917.64 |
| Education | $419.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,058.01 | 2021-2025 | |
| Genzyme Corporation | $1,739.97 | 2021-2025 | |
| Janssen Biotech, INC. | $1,726.61 | 2021-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $1,182.13 | 2021-2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $965.35 | 2022-2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $855.71 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $838.34 | 2021-2025 | Ilumya, Absorica Ld, Winlevi |
| Leo Pharma INC. | $702.90 | 2021-2025 | Adbry, Anzupgo |
| Lilly USA, LLC | $659.08 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Ucb, INC. | $583.28 | 2021-2025 | Bimzelx, Cimzia |
| Pfizer INC. | $441.92 | 2021-2025 | |
| Amgen INC. | $400.90 | 2022-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $260.99 | 2021-2025 | Nemluvio, Aklief |
| Incyte Corporation | $233.23 | 2022-2025 | Opzelura |
| Dermavant Sciences, INC. | $151.20 | 2024 | Vtama |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $137.26 | 2025 | Vtama |
| Arcutis Biotherapeutics, INC. | $135.18 | 2023-2024 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $130.38 | 2021-2024 | Cabtreo, Arazlo |
| Almirall LLC | $101.35 | 2022 | |
| Organogenesis INC. | $85.08 | 2024-2025 | Affinity, Puraply Wound Matrix |
| Epi Health, LLC | $57.39 | 2022 | |
| Vyne Pharmaceuticals INC. | $53.00 | 2021 | |
| Biofrontera INC. | $51.51 | 2022-2023 | Xepi, Bf-Rhodoled, Ameluz |
| Hill Dermaceuticals, INC. | $48.62 | 2024 | Tolak |
| Verrica Pharmaceuticals INC. | $19.18 | 2025 | Ycanth |
| Journey Medical Corporation | $17.32 | 2023 | |
| Sebela Pharmaceuticals INC. | $11.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassidy Conley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.